Evan Y. Yu, MD, discusses how systemic therapy options for newly diagnosed metastatic hormone-sensitive prostate cancer include androgen deprivation therapy (ADT) combined with chemotherapy or ...

Evan Y. Yu, MD, discusses how individualized first-line systemic therapy selection for metastatic hormone-sensitive prostate cancer (mHSPC) involves considering factors such as disease burden, patient ...

Amid rumors about Israeli PM Benjamin Netanyahu's prostate surgery, medical experts raise key questions about the procedure's ...

Treatment options include active surveillance (monitoring the cancer closely and opting for treatment if it progresses), radiation therapy, hormone therapy and chemotherapy. Surgery, specifically ...

Since it’s likely their patients will pursue complementary therapies during the course of their treatment ... prostate cancer progression, including biochemical recurrence, metastasis, hormone ...